Advanced imaging of corneal neovascularisation with a novel swept-source AS-OCTA system

利用新型扫频源AS-OCTA系统对角膜新生血管进行高级成像

阅读:1

Abstract

AIMS: To explore the clinical application of a novel swept-source anterior segment optical coherence tomography angiography (AS-OCTA) system for imaging corneal neovascularisation (CoNV), assessing limbal vasculature and detecting short-term vascular changes following pharmacologic vasoconstriction. METHODS: This cross-sectional observational study included 20 eyes: 10 with clinically diagnosed CoNV of various aetiologies and 10 healthy controls. Each eye underwent AS-OCTA imaging using the BMizar 400kHz Full-Range Swept-Source OCT system at baseline and after administration of 10% phenylephrine (PE). FlowArea (mm(2)) was automatically calculated across predefined circular regions of interest (ROIs) encompassing the cornea, limbus and episclera. In corneal and limbal ROIs, en face images were segmented into three depth layers: total (epithelium to endothelium), superficial (epithelium to 150 µm) and deep (150 µm to endothelium). RESULTS: CoNV eyes exhibited significantly higher total and deep corneal FlowArea compared with controls (p=0.0002 and p=0.0005, respectively). Post PE, a significant reduction in FlowArea was observed in the total and deep corneal layers of CoNV eyes (p=0.006 and p=0.009, respectively), and in the limbal region of both groups, with significant reductions observed in CoNV and controls (p=0.006 and p=0.003, respectively). CONCLUSIONS: This AS-OCTA platform enabled high-resolution, depth-resolved visualization of CoNV and revealed vascular changes following topical vasoconstriction. The extended field of view allowed simultaneous assessment of corneal, limbal and episcleral vasculature within a single scan session, supporting its potential role in both diagnostic evaluation and longitudinal monitoring of anterior segment diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。